Paper

Tumefactive multiple sclerosis (TMS): A case series of this challenging variant of MS.

Published Dec 26, 2020 · Joseph V Villarreal, Mariama Abraham, J. Acevedo

Multiple sclerosis and related disorders

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Case Report

Study Snapshot

Tumefactive multiple sclerosis (TMS) is a challenging disease to diagnose, but patients with TMS respond to disease-modifying agents like Glatiramer acetate and Dimethyl fumarate with similar disease progression as relapsing-remitting multiple sclerosis.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Tumefactive multiple sclerosis (TMS): A case series of this challenging variant of MS.

References

Citations